Related references
Note: Only part of the references are listed.Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression
Rudolf Uher et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Antidepressants on trial: how valid is the evidence?
Gordon Parker
BRITISH JOURNAL OF PSYCHIATRY (2009)
Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder: A Meta-Analysis Including 6562 Patients
Armin Szegedi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Genetic predictors of response to antidepressants in the GENDEP project
Rudolf Uher et al.
PHARMACOGENOMICS JOURNAL (2009)
The implications of gene-environment interactions in depression: will cause inform cure?
R. Uher
MOLECULAR PSYCHIATRY (2008)
Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches
Peter Lane
PHARMACEUTICAL STATISTICS (2008)
Observational research, randomised trials, and two views of medical science
Jan P. Vandenbroucke
PLOS MEDICINE (2008)
A latent-class mixture model for incomplete longitudinal Gaussian data
Caroline Beunckens et al.
BIOMETRICS (2008)
Measuring depression: comparison and integration of three scales in the GENDEP study
R. Uher et al.
PSYCHOLOGICAL MEDICINE (2008)
Methodological issues in current antipsychotic drug trials
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2008)
Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients
Hans H. Stassen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder
George I. Papakostas et al.
NEUROPSYCHOBIOLOGY (2007)
The Montgomery Asberg and the Hamilton ratings of depression: A comparison of measures
Thomas J. Carmody et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Early onset of selective serotonin reuptake inhibitor antidepressant action - Systematic review and meta-analysis
Matthew J. Taylor et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
Borwin Bandelow et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Dichotomizing continuous predictors in multiple regression: a bad idea
P Royston et al.
STATISTICS IN MEDICINE (2006)
Move over ANOVA - Progress in analyzing repeated-measures data and its reflection in papers published in the archives of general psychiatry
R Gueorguieva et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression
M Zimmerman et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2004)
Relationships among measures of treatment outcome in depressed patients
RT Mulder et al.
JOURNAL OF AFFECTIVE DISORDERS (2003)
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression
A Szegedi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline
PR Joyce et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2002)
Share Paper
